Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States

Emerging Infectious Diseases

Volumn 12, Issue 12, 2006, Pages 1827-1833

  Bernard, Susan M ^a   Anderson, Steven A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; DISEASE TRANSMISSION; DOG; DOMESTIC ANIMAL; ENVIRONMENTAL EXPOSURE; HAZARD ASSESSMENT; HUMAN; MONKEYPOX; NONHUMAN; PUBLIC HEALTH; QUALITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; UNITED STATES; VIRUS TRANSMISSION;

EID: 33845427933     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1212.060454     Document Type: Review

References (38)

1. Centers for Disease Control and Prevention. Update: multistate outbreak of monkeypox - Illinois, Indiana, Kansas, Missouri, Ohio, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:642-6.
2. Centers for Disease Control and Prevention. Multistate outbreak of monkeypox - Illinois, Indiana, and Wisconsin, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:537-40.
3. Reed KD, Melski JW, Graham MB, Regnery RL, Sotir MJ, Wegner MV, et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med. 2004;350:342-50.
4. Centers for Disease Control and Prevention. Monkeypox: report of cases in the United States. 2003. [cited 2006 Sept 26]. Available from http://www.cdc.gov/od/oc/media/mpv/cases.htm
5. Di Giulio DB, Eckburg PB. Human monkeypox. Lancet Infect Dis. 2004;4:199.
6. Hutin YJ, Williams RJ, Malfait P, Pebody R, Loparev VN, Ropp SL, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7:434-8.
7. Huhn GD, Bauer AM, Yorita K, Graham MB, Sejvar J, Likos A, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742-51.
8. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004;4:15-25.
9. Reynolds MG, Cono J, Curns A, Holman RC, Likos A, Regnery R, et al. Human monkeypox. Lancet Infect Dis. 2004;4:604-5.
10. Gerberding JL, McClellan MB. Joint Order of the Centers for Disease Control and Prevention and the Food and Drug Administration, Department of Health and Human Services. June 11, 2003. Available at 68 Fed Reg. 36566 (June 18, 2003).
11. Centers for Disease Control and Prevention. Control of communicable diseases; restrictions on African rodents, prairie dogs, and certain other animals. Interim final rule. Fed Regist. 2003;68:62353-69.
12. National Research Council. Risk assessment in the federal government: managing the process. Washington: National Academy Press; 1983.
13. Ladnyj ID, Ziegler P, Kima E. A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46:593-7.
14. Jezek Z, Szczeniowski M, Paluku KM, Mutombo M. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156:293-8.
15. Breman JG. Monkeypox: an emerging infection for humans? In: Scheld WM, Craig WA, Hughes JM, editors. Emerging Infections 4. Washington: ASM Press; 2000. p. 45-76.
16. Jezek Z, Fenner F. Human monkeypox, in Monographs on Virology. New York: Karger; 1988.
17. Khodakevich L, Szczeniowski M, Manbu-ma-Disu, Jezek Z, Marennikova S, Nakano J, et al. The role of squirrels in sustaining monkeypox virus transmission. Trop Geogr Med. 1987;39:115-22.
18. Guarner J, Johnson BJ, Paddock CD, Shieh WJ, Goldsmith CS, Reynolds MG, et al. Monkeypox transmission and pathogenesis in prairie dogs. Emerg Infect Dis. 2004;10:426-31.
19. Xiao SY, Sbrana E, Watts DM, Siirin M, da Rosa AP, Tesh RB. Experimental infection of prairie dogs with monkeypox virus. Emerg Infect Dis. 2005;11:539-45.
20. Anderson MG, Frenkel LD, Homann S, Guffey J. A case of severe monkeypox virus disease in an American child: emerging infections and changing professional values. Pediatr Infect Dis J. 2003;22:1093-6.
21. Jezek Z, Nakano JH, Arita I, Mutombo M, Szczeniowski M, Dunn C. Serological survey for human monkeypox infections in a selected population in Zaire. J Trop Med Hyg. 1987;90:31-8.
22. Jezek Z, Marennikova SS, Mutumbo M, Nakano JH, Paluku KM, Szczeniowski M. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986;154:551-5.
23. Meyer H, Perrichot M, Stemmler M, Emmerich P, Schmitz H, Varaine F, et al. Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol. 2002;40:2919-21.
24. Zaucha GM, Jahrling PB, Geisbert TW, Swearengen JR, Hensley L. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest. 2001;81:1581-600.
25. Esposito JJ, Knight JC. Orthopoxvirus DNA: a comparison of restriction profiles and maps. Virology. 1985;143:230-51.
26. Likos AM, Sammons SA, Olson VA, Frace AM, Li Y, Olsen-Rasmussen M, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86:2661-72.
27. Arita I, Jezek Z, Khodakevich L, Ruti K. Human monkeypox: a newly emerged orthopoxvirus zoonosis in the tropical rain forests of Africa. Am J Trop Med Hyg. 1985;34:781-9.
28. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998;54:693-702.
29. Antia R, Regoes RR, Koella JC, Bergstrom CT. The role of evolution in the emergence of infectious diseases. Nature. 2003;426:658-61.
30. Centers for Disease Control and Prevention. Updated interim CDC guidance for use of smallpox vaccine, cidofovir, and vaccinia immunoglobulin (VIG) for prevention and treatment in the setting of an outbreak of monkeypox infections. 2003. [cited 2006 Sep 26]. Available from www.cdc.gov/ncidod/monkeypox/ treatmentguidelines.hrm
31. Sejvar JJ, Chowdary Y, Schomogyi M, Stevens J, Patel J, Karem K, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis. 2004;190:1833-40.
32. Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, et al. Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. Nat Med. 2005;11:740-7.
33. Centers for Disease Control and Prevention. Human monkeypox - Kasai Oriental, Democratic Republic of Congo, February 1996-October 1997. MMWR Morb Mortal Wkly Rep. 1997;46:1168-71.
34. Khodakevich L, Jezek Z, Messinger D. Monkeypox virus: ecology and public health significance. Bull World Health Organ. 1988;66:747-52.
35. Breman JG, Nakano JH, Coffi E, Godfrey H, Gautun JC. Human poxvirus disease after smallpox eradication. Am J Trop Med Hyg. 1977;26:273-81.
36. Hutson CL, Lee KN, Abel J, Carroll DS, Montgomery JM, Olson VA, et al. Monkeypox zoonotic association: insights from laboratory evaluation of animals associated with the U.S. outbreak. Am J Trop Med Hyg. 2006; (in press).
37. Tesh RB, Watts DM, Sbrana E, Siirin M, Popov VL, Xiao S-Y. Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus. Emerg Infect Dis. 2004;10:1563-7.
38. US Department of the Interior; US Geological Survey. Investigating monkeypox in the wild. Factsheet 2004-3003. July 2004. [cited 2006 Jun 13]. Available from http://www.nwhc.usgs.gov/publications/fact_sheets/pdfs/ monkeypoxfinal_071504.pdf